• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Brain . Neuropsychiatric disorders following SARS-CoV-2 infection

tetano

Editor, Senior Moderator
Brain


. 2023 Feb 2;awad008.
doi: 10.1093/brain/awad008. Online ahead of print.
Neuropsychiatric disorders following SARS-CoV-2 infection


Paul J Harrison[SUP] 1 2 [/SUP], Maxime Taquet[SUP] 1 2 [/SUP]



Affiliations

Abstract

Several large-scale electronic health records studies have reported increased diagnostic rates for neuropsychiatric disorders following COVID-19 (SARS-CoV-2 infection), but many questions remain. To highlight the issues, we selectively review this literature, focussing on mood disorder, anxiety disorder, psychotic disorder, and cognitive impairment ('brain fog'). Eight key questions are addressed, comprising: (i) the nature and magnitude of the risks, (ii) their association with severity of infection, (iii) their duration, (iv) whether the risks differ between adults and children, or between men and women, (v) whether prior vaccination protects against them, (vi) the risk profile associated with different SARS-CoV-2 strains, (vii) what the underlying mechanisms might be, and (viii) whether the sequelae can be predicted. We consider the major unknowns, the limitations of electronic health records for research in this area, and the use of additional approaches to help characterise and understand the neuropsychiatric burden of COVID-19.

Keywords: coronavirus; epidemiology; health records; memory; mental health.
 
Back
Top Bottom